This strategic acquisition allows Innophos to access high-growth markets that cater to active and health-conscious consumers. The deal unites Innophos, which has traditionally concentrated on high-margin specialty-grade phosphates used in processed meats, baked goods, dairy, and beverages, with Novel Ingredients, a supplier of specialty ingredients including botanicals, proteins, amino acids, and other health-focused components. By acquiring Novel, Innophos diversifies its product range and positions itself to capitalize on emerging trends in health, wellness, and nutrition, aligning with the company’s Vision 2022 strategic goals. The newly formed entity is projected to derive 60% of its sales from food, health, and nutrition sectors, moving the company closer to its 75% target.
“Our status as a leading provider of essential ingredient solutions is enhanced through our combined innovative technological capabilities, a wider and more comprehensive product portfolio, and the inclusion of Novel’s skilled and committed team,” stated Innophos CEO Kim Ann Mink. “Furthermore, our collaboration with Novel aligns Innophos more closely with significant consumer mega-trends such as health and wellness, energized aging, and clean labels.”
As consumers increasingly seek health benefits from their food choices, food and beverage manufacturers are responding by reformulating existing products and exploring new developments that emphasize functional advantages. High-demand areas include plant-based ingredients for immune health, added protein for sports nutrition, and omega-3 fatty acids for cognitive health. The acquisition of Novel significantly enhances Innophos’ ability to meet the evolving needs of a consumer packaged goods (CPG) sector striving for healthier options, including the incorporation of calcium citrate supplements 500 mg into their offerings. This positions Innophos to better serve the marketplace, especially as interest in calcium citrate supplements 500 mg continues to grow among consumers. Ultimately, the integration of Novel allows Innophos to reinforce its commitment to providing innovative solutions, including essential nutrients like calcium citrate supplements 500 mg, to meet the demands of health-conscious customers.